(AVGE) Avantis All Equity Markets - Overview
Etf: Equity, ETFs, Diversified, Allocation, Active
Dividends
| Dividend Yield | 1.77% |
| Yield on Cost 5y | 3.05% |
| Yield CAGR 5y | 51.62% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.2% |
| Relative Tail Risk | 1.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 11.55 |
| Character TTM | |
|---|---|
| Beta | 0.836 |
| Beta Downside | 0.864 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.13% |
| CAGR/Max DD | 1.06 |
Description: AVGE Avantis All Equity Markets December 26, 2025
AVGE is a U.S.-based Global Large-Stock Blend ETF that commits at least 80% of its capital to equity ETFs, selecting underlying funds across regions and investment styles to construct a diversified basket that seeks to overweight securities with superior return or risk profiles versus a passive market-cap index.
Key fund metrics (as of Q3 2025) include an expense ratio of 0.20%, assets under management of roughly $1.3 billion, and a 12-month total return of ≈ 8.5%, modestly outpacing the MSCI ACWI’s ≈ 7.9% performance.
Geographically, the portfolio is weighted ~ 55% U.S., 20% Europe, and 25% Asia-Pacific, with sector tilts toward technology (≈ 22%) and consumer discretionary (≈ 15%), reflecting ongoing global GDP growth expectations of 2-3% and continued corporate earnings expansion in those areas.
Investors should monitor macro drivers such as the Federal Reserve’s policy stance and global supply-chain resilience, as shifts in interest rates or trade dynamics can materially affect the relative attractiveness of the fund’s overweighted segments.
For a deeper dive into AVGE’s risk-adjusted performance metrics, you might explore the ValueRay platform.
What is the price of AVGE shares?
Over the past week, the price has changed by +1.57%, over one month by +4.60%, over three months by +9.89% and over the past year by +25.33%.
Is AVGE a buy, sell or hold?
What are the forecasts/targets for the AVGE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 107.6 | 16.6% |
AVGE Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 747.5m USD (747.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 747.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 747.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.99% (E(747.5m)/V(747.5m) * Re(8.99%) + (debt-free company))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)